ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Illumina To Allow Nonhuman Sequencing

by Ann M. Thayer
October 12, 2015 | APPEARED IN VOLUME 93, ISSUE 40

[+]Enlarge
Credit: Illumina
A HiSeq X sequencer.
09340-buscon-hiseqxcxd.jpg
Credit: Illumina
A HiSeq X sequencer.

Illumina has extended the usage rights of its high-throughput next-generation gene sequencing systems to allow sequencing of nonhuman species. The firm hopes the move will expand the market for very large scale sequencing in areas such as agricultural research and model organisms for pharma R&D. The Wellcome Trust Sanger Institute, one of Illumina’s earliest customers for its HiSeq X Ten system, intends to conduct whole-genome sequencing projects on organisms of importance for public health, such as malaria and other pathogens.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment